A detailed history of Chilton Capital Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Chilton Capital Management LLC holds 114 shares of BSX stock, worth $9,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114
Previous 85 34.12%
Holding current value
$9,504
Previous $5,000 60.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$67.33 - $77.71 $1,952 - $2,253
29 Added 34.12%
114 $8,000
Q1 2024

May 07, 2024

BUY
$57.6 - $68.62 $4,896 - $5,832
85 New
85 $5,000
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $142,033 - $157,594
3,150 New
3,150 $157,000
Q2 2022

Aug 16, 2022

BUY
$35.24 - $47.1 $7,118 - $9,514
202 New
202 $8,000
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $8,261 - $9,110
-202 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $7,690 - $9,063
202 New
202 $9,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.